Inventor
CLAIRMONT KEVIN B
US8 patents
⚠️ This page may combine multiple inventors who share the name “CLAIRMONT KEVIN B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BAYER PHARMACEUTICALS CORP
6 patentsUS7041646B2May 9, 2006
Methods of treating type 2 diabetes with peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists
BAYER PHARMACEUTICALS CORP43 citations91
US6864069B2Mar 8, 2005
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
BAYER PHARMACEUTICALS CORP34 citations91
US7494978B2Feb 24, 2009
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
BAYER PHARMACEUTICALS CORP0 citations50
US7488714B2Feb 10, 2009
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
BAYER PHARMACEUTICALS CORP0 citations50
US7488716B2Feb 10, 2009
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
BAYER PHARMACEUTICALS CORP0 citations50
US7488715B2Feb 10, 2009
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
BAYER PHARMACEUTICALS CORP0 citations50